Ontology highlight
ABSTRACT: Background
Glioblastoma (GBM) is the most aggressive form of brain tumor and has vascular-rich features. The S100A4/non-muscle myosin IIA (NMIIA) axis contributes to aggressive phenotypes in a variety of human malignancies, but little is known about its involvement in GBM tumorigenesis. Herein, we examined the role of the S100A4/NMIIA axis during tumor progression and vasculogenesis in GBM.Methods
We performed immunohistochemistry for S100A4, NMIIA, and two hypoxic markers, hypoxia-inducible factor-1α (HIF-1α) and carbonic anhydrase 9 (CA9), in samples from 94 GBM cases. The functional impact of S100A4 knockdown and hypoxia were also assessed using a GBM cell line.Results
In clinical GBM samples, overexpression of S100A4 and NMIIA was observed in both non-pseudopali
SUBMITTER: Inukai M
PROVIDER: S-EPMC8991692 | biostudies-literature | 2022 Apr
REPOSITORIES: biostudies-literature